Alhydrogel® clinical trials

A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Diamyd® to Preserve Endogenous Beta Cell Function in Adolescents and Adults with Recently Diagnosed Type 1 Diabetes, Carrying the Genetic HLA DR3-DQ2 Haplotype

This study looks at a new treatment called Diamyd for teenagers and adults recently diagnosed with Type 1 diabetes. Researchers want to see if it can help preserve the body's natural ability to make insulin. It’s a major study to check how well it works and if it's safe.